We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

SpeeDx and Thermo Fisher Scientific Partner for FDA Clearance of Molecular Diagnostic Test

News   May 12, 2017

 
SpeeDx and Thermo Fisher Scientific Partner for FDA Clearance of Molecular Diagnostic Test
 
 
Advertisement
 

RELATED ARTICLES

Previous SARS-CoV-2 Infection Prevents Reinfection for at Least 6 Months

News

A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again, for at least six months following their first infection.

READ MORE

Oxford Coronavirus Vaccine Elicits a Robust Immune Response in Older Adults

News

Data from the ChAdOx1 nCov-2019 coronavirus vaccine study suggests that one of the groups most vulnerable to serious illness and death from COVID-19, could build robust immunity following vaccination.

READ MORE

Blood Test Picks Out Cancers Likely To Benefit From Targeted Drugs

News

A simple and inexpensive blood test could pick out patients with stomach or oesophageal cancer who are likely to benefit from targeted treatment, a new study shows.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE